Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Damaris Meyn"'
Autor:
Joachim Andreas Koeck, Heike Hilgarth, Andreas von Ameln-Mayerhofer, Damaris Meyn, Ruediger Warlich, Andreas Münstedt, Dagmar Horn, Christina König
Publikováno v:
Antibiotics, Vol 10, Iss 11, p 1330 (2021)
Patients in intensive care units (ICUs) are at high risk of drug–drug interactions (DDIs) due to polypharmacy. Little is known about type and frequency of DDIs within German ICUs. Clinical pharmacists’ interventions (PI) recorded in a national da
Externí odkaz:
https://doaj.org/article/a954d48872ce4c0a83e722015168be25
Autor:
Elisabeth Mack, Damaris Meyn, Carmen Schade-Brittinger, Hinnerk Wulf, Ralf Michael Muellenbach, Thomas Wiesmann, Johannes Johow, Claus Vogelmeier, Joachim Hoyer, Caroline Rolfes, Christian Keller, Andreas Neubauer, Iuliu Torje, Chrysanthi Skevaki, Andrea Kadlubiec, Andreas Burchert
Publikováno v:
Leukemia
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 (coronavirus disease 2019), which is associated with high morbidity and mortality, especially in elder patients. Acute respiratory distress syndrome (ARDS) is a life-threate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6cf0aa496719504301f4d443cb6b61d
http://europepmc.org/articles/PMC8358255
http://europepmc.org/articles/PMC8358255
Autor:
Ruediger Warlich, Heike Hilgarth, Andreas von Ameln-Mayerhofer, Joachim Andreas Koeck, Dagmar Horn, Christina König, Damaris Meyn, Andreas Münstedt
Publikováno v:
Antibiotics
Volume 10
Issue 11
Antibiotics, Vol 10, Iss 1330, p 1330 (2021)
Volume 10
Issue 11
Antibiotics, Vol 10, Iss 1330, p 1330 (2021)
Patients in intensive care units (ICUs) are at high risk of drug–drug interactions (DDIs) due to polypharmacy. Little is known about type and frequency of DDIs within German ICUs. Clinical pharmacists’ interventions (PI) recorded in a national da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dd4d8374c46ba008f1d8cd743284cdc
Publikováno v:
International Journal of Clinical Pharmacy
Background With a clinical pharmacists’ participation in an intensive care unit (ICU) previous international studies have shown a reduction of medication errors, drug costs and improvements of clinical outcomes. Still there is a lack of qualitative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ccb64fe8e835316d3e7340fce208d23
https://doi.org/10.1007/s11096-019-00874-8
https://doi.org/10.1007/s11096-019-00874-8
Autor:
Johannes Johow, Joachim Hoyer, Claus Vogelmeier, Hinnerk Wulf, Thomas Wiesmann, Caroline Rolfes, Elisabeth Mack, Ralf Michael Muellenbach, Christian Keller, Andreas Neubauer, Carmen Schade-Brittinger, Iuliu Torje, Chrysanthi Skevaki, Andrea Kadlubiec, Damaris Meyn, Andreas Burchert
Publikováno v:
Leukemia
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 (coronavirus disease 2019), which is associated with high morbidity and mortality, especially in elder patients. Acute respiratory distress syndrome (ARDS) is a life-threate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04b668ae3ce8b52058d9f0ae5eb91c6e
http://europepmc.org/articles/PMC8436193
http://europepmc.org/articles/PMC8436193